pbi-shRNA STMN1 Lipoplex

N/A

Report date: 2022/02/07 16:38:31

NME

Base Information

Drug Namepbi-shRNA STMN1 Lipoplex

Drug Alias Namepbi-shRNA STMN1 LPpbi-shSTMN1 LP

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA

Mechanisms of ActionRNA interferenceStathmin inhibitors

TargetsStathmin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGradalis Inc

China Registration ClassN/A

Active CompaniesGradalis Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

ATC CodeN/A